| Active substance |
Metformin, Voglibose |
| Also known as |
AO-128 |
| Blood pressure |
No direct effect |
| Chemical name |
(1S,2R,3R,4R,5S)-5-(2-hydroxy-1-(hydroxymethyl)ethyl)-1,2,3,4-cyclohexanetetrol |
| Dosage (medical) |
Typically 0.2 mg to 0.3 mg three times a day with the first bite of each main meal |
| Dosage (sports) |
Not applicable as voglibose is not used for performance enhancement in sports |
| Effects |
Reduces postprandial blood glucose levels |
| Formula |
C10H21NO7 |
| Half-life |
1.5 - 4.5 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specific, generally monitored through blood glucose levels |
| Main action |
Delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals |
| Side effects |
Flatulence, diarrhea, abdominal pain |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
0.2/500mg |
| Substance class |
Alpha-glucosidase inhibitor |
| Trade name |
Vogliban, Basen, Vocarb |
| Use in sports |
None |
| Water Retention |
No significant effect |
| Manufacturer |
Healing Pharma |
| Packing |
10 tabs/blister |
